| Literature DB >> 28985523 |
Duanqing Pei1, David W Beier2, Ephrat Levy-Lahad3, Gary Marchant4, Janet Rossant5, Juan Carlos Izpisua Belmonte6, Robin Lovell-Badge7, Rudolf Jaenisch8, Alta Charo9, David Baltimore10.
Abstract
A recent National Academies report articulates a path forward for research, ethics, and governance of clinical applications involving genome editing. In light of recent human embryo editing developments, scientists and stakeholders from all nations should cooperate to take advantage of this historic opportunity for medicine and also basic human biology.Entities:
Mesh:
Year: 2017 PMID: 28985523 DOI: 10.1016/j.stem.2017.09.010
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633